Partnering News

Peoples Gas Partners with Pitt

September 21, 2022 - PITTSBURGH--(BUSINESS WIRE)--The University of Pittsburgh and Peoples Gas, an Essential Utilities company, are teaming up to explore the use of hydrogen as a future energy source. Together, the organizations announced today they will enter a research partnership to study the potential of safely and securely transporting hydrogen through its natural gas systems. Read full article » 

Coeptis Therapeutics Enters Exclusive License Agreement with University of Pittsburgh

Sept. 21, 2022 - Coeptis Therapeutics, Inc., a biopharmaceutical company developing innovative cell therapy platforms for cancer, today announced entry into an exclusive license agreement with the University of Pittsburgh for the rights to a chimeric antigen receptor T cell (CAR T) technology – SNAP-CAR – designed to target multiple antigens simultaneously and potentially address a range of hematologic and solid tumors, including breast and ovarian cancer. Completion of the exclusive license agreement for SNAP-CAR follows Coeptis' entry into an option agreement with the University of Pittsburgh announced in May 2022. Read full article »

ElevateBio and the University of Pittsburgh Announce Creation of Pitt BioForge BioManufacturing Center at Hazelwood Green to Accelerate Cell and Gene Therapy Innovation

August 25, 2022 – ElevateBio, LLC (ElevateBio) and the University of Pittsburgh announced they have entered into a long-term strategic partnership to accelerate the development of highly innovative cell and gene therapies. Through this agreement, ElevateBio will locate one of its next BaseCamp process development and Good Manufacturing Practice (GMP) manufacturing facilities in Pittsburgh, fully equipped with its enabling technologies, including gene editing, induced pluripotent stem cell (iPSC) and cell, vector, and protein engineering capabilities. The University of Pittsburgh has long been a research powerhouse and is consistently among the top U.S. institutions in National Institutes of Health research funding. Read full article »

Coeptis Therapeutics Enters into Exclusive Option Agreement with University of Pittsburgh

May 17, 2022 - Coeptis Therapeutics, Inc. (OTC PINK: COEP) ("Coeptis" or "the Company"), a biopharmaceutical company developing innovative cell therapy platforms for cancer, today announced entry into an exclusive option agreement with the University of Pittsburgh for the rights to three chimeric antigen receptor T cell (CAR-T) technologies that offer the potential to address a range of hematologic and solid tumors. Among the initial cancer indications under development are pre-clinical programs targeting breast cancer and ovarian cancer. Read full article »

Pitt-UPMC-Bayer Collaboration to fight Chronic Kidney Disease

May 13, 2022 - One in seven American adults — 37 million people — have chronic kidney disease (CKD), an incurable condition with few treatments available to slow its progression or delay organ failure. Read full article »

Cultivating Industry-Academia Partnerships

April 23, 2022 - Pitt's Office of Industry and Economic Partnerships was recently featured in the University-Industry Engagement Advisor for its efforts to implement a more targeted marketing strategy focused on high-value opportunities.

Historically, large research universities have marketed their available technologies and start-ups by solely listing them on the university portal. More recently, the universities of Virginia, Michigan and Pittsburgh have developed and are using a more targeted approach to reach prospective partners and it's working. Read full article »

Pitt and Duquesne Light Partner for a Powerful Future

January 4, 2022 - To keep pace with the rapidly evolving technology of electric power systems, the University of Pittsburgh Energy GRID Institute and Duquesne Light Co. (DLC) are partnering to create a collaborative platform to advance and implement innovative solutions in support of a more secure, resilient, and clean energy grid. Read full article »

The University of Pittsburgh and Orange Grove Bio Establish Partnership to Develop and Commercialize Novel Therapeutics

NEW YORK and PITTSBURGH, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Orange Grove Bio, a preclinical drug investment and development firm, and the University of Pittsburgh today announced the establishment of a collaboration designed to advance the development and commercialization of novel therapeutics by supporting the translation of scientific discoveries made by researchers at the University of Pittsburgh. The newly established partnership will aim to cultivate the Pittsburgh biotech landscape by increasing entrepreneurship, education, and scientific translation of promising technologies. These efforts will be focused in the areas of oncology and autoimmune and inflammatory diseases. Read full article »

Covestro LLC and University of Pittsburgh collaborate to establish groundbreaking Circular Economy Program

November 16, 2021 - A new collaboration between the University of Pittsburgh and Covestro LLC takes aim at decreasing global waste and its impact on the environment and climate.The Covestro Circular Economy Program will enable students at the University of Pittsburgh to become experts in circular economy principles, informed by Covestro’s successes in this area, and ultimately create circular, sustainable products and service solutions. Read full article » 

Astellas and University of Pittsburgh